keyword
https://read.qxmd.com/read/37699886/artemisinins-inhibit-oral-candidiasis-caused-by-candida-albicans-through-the-repression-on-its-hyphal-development
#21
JOURNAL ARTICLE
Xiaoyue Liang, Ding Chen, Jiannan Wang, Binyou Liao, Jiawei Shen, Xingchen Ye, Zheng Wang, Chengguang Zhu, Lichen Gou, Xinxuan Zhou, Lei Cheng, Biao Ren, Xuedong Zhou
Candida albicans is the most abundant fungal species in oral cavity. As a smart opportunistic pathogen, it increases the virulence by switching its forms from yeasts to hyphae and becomes the major pathogenic agent for oral candidiasis. However, the overuse of current clinical antifungals and lack of new types of drugs highlight the challenges in the antifungal treatments because of the drug resistance and side effects. Anti-virulence strategy is proved as a practical way to develop new types of anti-infective drugs...
September 12, 2023: International Journal of Oral Science
https://read.qxmd.com/read/37634761/identification-of-covalent-fragment-inhibitors-for-plasmodium-falciparum-uchl3-with-anti-malarial-efficacy
#22
JOURNAL ARTICLE
Ryan D Imhoff, Melissa R Rosenthal, Kutub Ashraf, Purnima Bhanot, Caroline L Ng, Daniel P Flaherty
Malaria continues to be a major burden on global health, responsible for 619,000 deaths in 2021. The causative agent of malaria is the eukaryotic parasite Plasmodium. Resistance to artemisinin-based combination therapies (ACTs), the current first-line treatment for malaria, has emerged in Asia, South America, and more recently Africa, where >90% of all malaria-related deaths occur. This has necessitated the identification and investigation of novel parasite proteins and pathways as antimalarial targets, including components of the ubiquitin proteasome system...
August 25, 2023: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/37551137/dihydroartemisinin-inhibits-plasmid-transfer-in-drug-resistant-escherichia-coli-via-limiting-energy-supply
#23
JOURNAL ARTICLE
Xue-Yang Wang, Huang-Wei Song, Tian Yi, Ying-Bo Shen, Chong-Shan Dai, Cheng-Tao Sun, De-Jun Liu, Jian-Zhong Shen, Cong-Ming Wu, Yang Wang
Conjugative transfer of antibiotic resistance genes (ARGs) by plasmids is an important route for ARG dissemination. An increasing number of antibiotic and nonantibiotic compounds have been reported to aid the spread of ARGs, highlighting potential challenges for controlling this type of horizontal transfer. Development of conjugation inhibitors that block or delay the transfer of ARG-bearing plasmids is a promising strategy to control the propagation of antibiotic resistance. Although such inhibitors are rare, they typically exhibit relatively high toxicity and low efficacy in vivo and their mechanisms of action are inadequately understood...
September 18, 2023: Zoological Research
https://read.qxmd.com/read/37542987/current-development-of-1-2-3-triazole-derived-potential-antimalarial-scaffolds-structure-activity-relationship-sar-and-bioactive-compounds
#24
REVIEW
S Maheen Abdul Rahman, Jasvinder Singh Bhatti, Suresh Thareja, Vikramdeep Monga
Malaria is among one of the most devastating and deadliest parasitic disease in the world claiming millions of lives every year around the globe. It is a mosquito-borne infectious disease caused by various species of the parasitic protozoan of the genus Plasmodium. The indiscriminate exploitation of the clinically used antimalarial drugs led to the development of various drug-resistant and multidrug-resistant strains of plasmodium which severely reduces the therapeutic effectiveness of most frontline medicines...
July 30, 2023: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/37406517/novel-bis-artemisinin-phloroglucinol-hybrid-molecules-with-dual-anticancer-and-immunomodulatory-activities-synthesis-and-evaluation
#25
JOURNAL ARTICLE
Wei Xu, Xiaosu Zou, Yufeng Zha, Jinghua Zhang, Hongzhu Bian, Zhengwu Shen
Bis-(10-deoxydihydroartemisinin)-phloroglucinol (9), has been synthesized in a one-step reaction and has demonstrated strong inhibition to cancer cell proliferation and immunosuppressive activity. The structure modification of the compound reduced its cytotoxicity, and among the analogs, bis-(10-deoxydihydroartemisinin)-phloroglucinol phenyl decanoate (16) showed significant reduction of ear swelling in a mouse model for DNFB-induced delayed-type hypersensitivity without observable toxicity in a dose-dependent manner...
June 30, 2023: Bioorganic Chemistry
https://read.qxmd.com/read/37321306/nitric-oxide-induces-antioxidant-machinery-psii-functioning-and-artemisinin-biosynthesis-in-artemisia-annua-under-cadmium-stress
#26
JOURNAL ARTICLE
Kaiser Iqbal Wani, M Naeem, M Masroor A Khan, Tariq Aftab
Soil contamination by heavy metals poses a significant environmental challenge, as the practical implementation of existing remediation technologies in the field has encountered numerous obstacles. This has necessitated the requirement of finding alternate solutions to reduce the harm caused to plants. In this study, nitric oxide (NO) was investigated for its potential to reduce cadmium (Cd) toxicity in A. annua plants. Although NO plays a vital role in the growth and development of plants, information on its role in reducing abiotic stress in plants is limited...
June 13, 2023: Plant Science: An International Journal of Experimental Plant Biology
https://read.qxmd.com/read/37306362/discovery-of-platinum-iv-artesunate-multiaction-prodrugs-as-potent-antitumor-and-antimalarial-agents
#27
JOURNAL ARTICLE
Wei Liu, Chuyi Yu, Miaomiao Wang, Youyou He, Zhongjie Guo, Jin He, Ru Jiang, Qin Xu, Jianming Liang, Shengzheng Wang
Recently, artemisinin and derivatives have been revealed to possess encouraging antitumor activity. Herein, we integrated the antitumor advantages of artesunate and platinum drugs to construct novel PtIV -artesunate dual-action and triple-action complexes. Most derivatives, especially 10f , displayed broad-spectrum and potent in vitro antitumor activities against a number of cancer cell lines. Compound 10f displayed potent antimetastasis and anticlonogenic activities, efficiently induced autophagic cell death and apoptosis, and arrested the cell cycle at both S and G2/M phases...
June 12, 2023: Journal of Medicinal Chemistry
https://read.qxmd.com/read/37273554/repurposing-dihydroartemisinin-to-combat-oral-squamous-cell-carcinoma-associated-with-mitochondrial-dysfunction-and-oxidative-stress
#28
JOURNAL ARTICLE
Shanwei Shi, Huigen Luo, Yuna Ji, Huiya Ouyang, Zheng Wang, Xinchen Wang, Renjie Hu, Lihong Wang, Yun Wang, Juan Xia, Bin Cheng, Baicheng Bao, Xin Li, Guiqing Liao, Baoshan Xu
Oral squamous cell carcinoma (OSCC), with aggressive locoregional invasion, has a high rate of early recurrences and poor prognosis. Dihydroartemisinin (DHA), as a derivative of artemisinin, has been found to exert potent antitumor activity. Recent studies reported that DHA suppresses OSCC cell growth and viability through the regulation of reactive oxygen species (ROS) production and mitochondrial calcium uniporter. However, the mechanism underlying the action of DHA on OSCCs remains elusive. In the study, we observed that 159 genes were remarkably misregulated in primary OSCC tumors associated with DHA-inhibited pathways, supporting that OSCCs are susceptible to DHA treatment...
2023: Oxidative Medicine and Cellular Longevity
https://read.qxmd.com/read/37249624/art714-is-a-best-in-class-antileukemic-2-carbon-linked-dimeric-artemisinin-derivative
#29
JOURNAL ARTICLE
Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai, Nicole M Anders, Stephen W Hoag, Michelle A Rudek, Curt I Civin
PURPOSE: It has become increasingly clear that new multiagent combination regimens are required to improve survival rates in acute myeloid leukemia (AML). We recently reported that ART631, a first-in-class 2-carbon-linked artemisinin-derived dimer (2C-ART), was not only efficacious as a component of a novel three-drug combination regimen to treat AML, but, like other synthetic artemisinin derivatives, demonstrated low clinical toxicity. However, we ultimately found ART631 to have suboptimal solubility and stability properties, thus limiting its potential for clinical development...
May 30, 2023: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/37238706/favorable-preclinical-pharmacological-profile-of-a-novel-antimalarial-pyrrolizidinylmethyl-derivative-of-4-amino-7-chloroquinoline-with-potent-in-vitro-and-in-vivo-activities
#30
JOURNAL ARTICLE
Nicoletta Basilico, Silvia Parapini, Sarah D'Alessandro, Paola Misiano, Sergio Romeo, Giulio Dondio, Vanessa Yardley, Livia Vivas, Shereen Nasser, Laurent Rénia, Bruce M Russell, Rossarin Suwanarusk, François Nosten, Anna Sparatore, Donatella Taramelli
The 4-aminoquinoline drugs, such as chloroquine (CQ), amodiaquine or piperaquine, are still commonly used for malaria treatment, either alone (CQ) or in combination with artemisinin derivatives. We previously described the excellent in vitro activity of a novel pyrrolizidinylmethyl derivative of 4-amino-7-chloroquinoline, named MG3, against P. falciparum drug-resistant parasites. Here, we report the optimized and safer synthesis of MG3 , now suitable for a scale-up, and its additional in vitro and in vivo characterization...
May 14, 2023: Biomolecules
https://read.qxmd.com/read/37233654/secondary-metabolites-isolated-from-artemisia-afra-and-artemisia-annua-and-their-anti-malarial-anti-inflammatory-and-immunomodulating-properties-pharmacokinetics-and-pharmacodynamics-a-review
#31
REVIEW
Lahngong Methodius Shinyuy, Gisèle E Loe, Olivia Jansen, Lúcia Mamede, Allison Ledoux, Sandra Fankem Noukimi, Suh Nchang Abenwie, Stephen Mbigha Ghogomu, Jacob Souopgui, Annie Robert, Kristiaan Demeyer, Michel Frederich
There are over 500 species of the genus Artemisia in the Asteraceae family distributed over the globe, with varying potentials to treat different ailments. Following the isolation of artemisinin (a potent anti-malarial compound with a sesquiterpene backbone) from Artemisia annua , the phytochemical composition of this species has been of interest over recent decades. Additionally, the number of phytochemical investigations of other species, including those of Artemisia afra in a search for new molecules with pharmacological potentials, has increased in recent years...
April 29, 2023: Metabolites
https://read.qxmd.com/read/37211335/cinnamigones-a-c-three-highly-oxidized-guaiane-type-sesquiterpenes-with-neuroprotective-activity-from-cinnamomum-migao
#32
JOURNAL ARTICLE
Lang Zhou, Li-Shou Yang, Li Wang, Hua-Dan Liu, Ming Gao, Fa-Ju Chen, Juan Yang, Qi-Ji Li, Xiao-Sheng Yang
Cinnamigones A-C, three undescribed highly oxidized guaiane-type sesquiterpenes were isolated from the fruits of Cinnamomum migao. Cinnamigone A (1), structurally artemisinin-like, is a natural 1,2,4-trioxane caged endoperoxide with an unprecedented tetracyclic 6/6/7/5 ring system. Compounds 2-3 are classic guaiane sesquiterpene featuring different epoxy units. Guaiol (4) is considered to be the precursor of 1-3 in the biosynthesis pathway hypothesis. The planar structures and configurations of cinnamigones A-C were elucidated by spectral analysis, HRESIMS, X-ray crystallography and ECD calculations...
May 19, 2023: Phytochemistry
https://read.qxmd.com/read/37183476/a-novel-outlook-in-the-delivery-of-artemisinin-production-and-efficacy-in-experimental-visceral-leishmaniasis
#33
JOURNAL ARTICLE
Maryam Akbari, Hossein Heli, Ahmad Oryan, Gholamreza Hatam
The visceral form of leishmaniasis (VL), due to infection by Leishmania infantum , is a neglected tropical disease. The accessible therapeutic options are limited. Artemisinin is an efficient antileishmanial product with poor biological availability that requires high repetition of therapeutic doses in VL. Solid lipid nanoparticles (SLNs) provide targeted delivery, increase bioavailability and reduce toxicity of the traditional therapeutic strategy. The spherical shape artemisinin-loaded SLNs were prepared in a particle diameter of 222...
May 15, 2023: Pathogens and Global Health
https://read.qxmd.com/read/37182516/medicinal-and-mechanistic-overview-of-artemisinin-in-the-treatment-of-human-diseases
#34
REVIEW
Anna Maria Posadino, Roberta Giordo, Gianfranco Pintus, Soheb Anwar Mohammed, Ilkay Erdogan Orhan, Patrick Valere Tsouh Fokou, Farukh Sharopov, Charles Oluwaseun Adetunji, Zehra Gulsunoglu-Konuskan, Alibek Ydyrys, Lorene Armstrong, Oksana Sytar, Miquel Martorell, Ahmad Faizal Abdull Razis, Babagana Modu, Daniela Calina, Solomon Habtemariam, Javad Sharifi-Rad, William C Cho
Artemisinin (ART) is a bioactive compound isolated from the plant Artemisia annua and has been traditionally used to treat conditions such as malaria, cancer, viral infections, bacterial infections, and some cardiovascular diseases, especially in Asia, North America, Europe and other parts of the world. This comprehensive review aims to update the biomedical potential of ART and its derivatives for treating human diseases highlighting its pharmacokinetic and pharmacological properties based on the results of experimental pharmacological studies in vitro and in vivo...
May 12, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/37156929/enhanced-anti-cancer-effect-of-artemisinin-and-curcumin-loaded-niosomal-nanoparticles-against-human-colon-cancer-cells
#35
JOURNAL ARTICLE
Akram Firouzi Amandi, Elham Jokar, Majid Eslami, Mehdi Dadashpour, Mehdi Rezaie, Yalda Yazdani, Babak Nejati
Colorectal cancer (CRC) is the third broadly identified cancer in the world. The ineffectiveness of colorectal cancer treatment is redundantly reported. Natural bioactive compounds have gained popularity in reducing the drawback of conventional anti-cancer agents. Curcumin (Cur) and Artemisinin (Art) are materials of a natural source that have been utilized to treat numerous kinds of cancers. Although the benefits of bioactive materials, their utilization is limited because of poor solubility, bioavailability, and low dispersion rate in aqueous media...
May 8, 2023: Medical Oncology
https://read.qxmd.com/read/37108079/anti-mitochondrial-and-insecticidal-effects-of-artemisinin-against-drosophila-melanogaster
#36
JOURNAL ARTICLE
Mengjiao Zhong, Chen Sun, Bing Zhou
Artemisinin (ART) is an endoperoxide molecule derived from the medicinal plant Artemisia annua L. and is clinically used as an antimalarial drug. As a secondary metabolite, the benefit of ART production to the host plant and the possible associated mechanism are not understood. It has previously been reported that Artemisia annua L. extract or ART can inhibit both insect feeding behaviors and growth; however, it is not known whether these effects are independent of each other, i.e., if growth inhibition is a direct outcome of the drug's antifeeding activity...
April 7, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37105515/b7-h3-but-not-pd-l1-is-involved-in-the-antitumor-effects-of-dihydroartemisinin-in-non-small-cell-lung-cancer
#37
JOURNAL ARTICLE
Bing-Qi Hu, Jun-Feng Huang, Ke Niu, Jing Zhou, Nan-Nan Wang, Yu Liu, Li-Wen Chen
Dihydroartemisinin (DHA), an active antimalaria metabolite derived from artemisinin, has received increasing attention for its anticancer activities. However, little is known about the anticancer mechanisms of DHA, although the existing data define its antimalaria effects by producing excessive reactive oxygen species (ROS). In this study, we showed that DHA effectively suppresses in vitro and in vivo tumor growth of non-small cell lung cancer (NSCLC) without perceptible toxicity on heart, liver, spleen, lung, and kidney tissues...
April 25, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/37073152/role-of-nanomedicines-in-controlling-malaria-a-review
#38
JOURNAL ARTICLE
Sakshi Sharma, Kamla Rawat, Himadri B Bohidar
Malaria has created havoc since time immemorial. It has actually become a major health concern due to its high prevalence in developing countries where poor sanitary conditions facilitate the seasonal breeding of the vector, the female Anopheles mosquito. Even after tremendous advancements in pest control and pharmacology science, managing this disease has not been successful, and the cure for this deadly infection has not proven effective lately. The various conventional drugs used are chloroquine, primaquine, mefloquine, atovaquone, quinine, artemisinin etc...
April 17, 2023: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/37067430/chemogenomic-profiling-of-a-plasmodium-falciparum-transposon-mutant-library-reveals-shared-effects-of-dihydroartemisinin-and-bortezomib-on-lipid-metabolism-and-exported-proteins
#39
JOURNAL ARTICLE
Camilla Valente Pires, Jenna Oberstaller, Chengqi Wang, Debora Casandra, Min Zhang, Jyotsna Chawla, Swamy Rakesh Adapa, Thomas D Otto, Michael T Ferdig, Julian C Rayner, Rays H Y Jiang, John H Adams
The antimalarial activity of the frontline drug artemisinin involves generation of reactive oxygen species (ROS) leading to oxidative damage of parasite proteins. To achieve homeostasis and maintain protein quality control in the overwhelmed parasite, the ubiquitin-proteasome system kicks in. Even though molecular markers for artemisinin resistance like pfkelch13 have been identified, the intricate network of mechanisms driving resistance remains to be elucidated. Here, we report a forward genetic screening strategy that enables a broader identification of genetic factors responsible for altering sensitivity to dihydroartemisinin (DHA) and a proteasome inhibitor, bortezomib (BTZ)...
April 17, 2023: Microbiology Spectrum
https://read.qxmd.com/read/37065442/susceptibility-of-cervical-cancer-to-dihydroartemisinin-induced-ferritinophagy-dependent-ferroptosis
#40
JOURNAL ARTICLE
Hanqiang Shi, Lie Xiong, Guang Yan, Shuqin Du, Jie Liu, Yanbo Shi
The clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and chemotherapy. Dihydroartemisinin (DHA), the primary active metabolites of artemisinin and its derivatives, has exhibited a variety of anticancer properties with low toxicity. However, the role of DHA and ferroptosis in cervical cancer remained unclear. Here, we showed that DHA could time-dependently and dose-dependently inhibit the proliferation of cervical cancer cells, which could be alleviated by the inhibitors of ferroptosis rather than apoptosis...
2023: Frontiers in Molecular Biosciences
keyword
keyword
31860
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.